BridgeBio have substantially improved the progress of a new therapy for cardiac amyloidosis, utilizing the investigational drug. Initial trial results suggests significant improvements for individuals suffering by this https://bridgebio321855.bloggosite.com/50112103/bridgebio-improves-cardiac-amyloidosis-treatment-through-attruby